Source: Neuropsychiatric disease and treatment. Unidade: FM
Subjects: LÍTIO (FARMACOLOGIA;USO TERAPÊUTICO), ESTRESSE OXIDATIVO, TRANSTORNOS NEUROPSICOLÓGICOS, DOENÇA DE ALZHEIMER (PREVENÇÃO E CONTROLE), NEUROPSIQUIATRIA
ABNT
DINIZ, Breno Satler e MACHADO-VIEIRA, Rodrigo e FORLENZA, Orestes Vicente. Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatric disease and treatment, v. 9, p. 493-500, 2013Tradução . . Disponível em: https://doi.org/10.2147/NDT.S33086. Acesso em: 18 ago. 2024.APA
Diniz, B. S., Machado-Vieira, R., & Forlenza, O. V. (2013). Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatric disease and treatment, 9, 493-500. doi:10.2147/NDT.S33086NLM
Diniz BS, Machado-Vieira R, Forlenza OV. Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders [Internet]. Neuropsychiatric disease and treatment. 2013 ; 9 493-500.[citado 2024 ago. 18 ] Available from: https://doi.org/10.2147/NDT.S33086Vancouver
Diniz BS, Machado-Vieira R, Forlenza OV. Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders [Internet]. Neuropsychiatric disease and treatment. 2013 ; 9 493-500.[citado 2024 ago. 18 ] Available from: https://doi.org/10.2147/NDT.S33086